cardiab.com/article
Bottom,Top,Right1
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
Cardiovascular Diabetology
official impact factor 3.35
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My Cardiovascular Diabetology

Submit a manuscript Register Sign up for article alerts Contact us Follow
BioMed Central
Support

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Archive
  • Article collections

Page 1 of 4

1 2 3 4  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

1.

1448
Accesses

Original investigation   Open Access Highly Accessed

Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study

Antoinette V Buys, Mia-Jean Van Rooy, Prashilla Soma, Dirk Van Papendorp, Boguslaw Lipinski, Etheresia Pretorius Cardiovascular Diabetology 2013, 12:25 (28 January 2013)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

2.

1070
Accesses

Original investigation   Open Access

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report

Hirofumi Suzuki, Masaya Sakamoto, Takeshi Hayashi, Hiroyuki Iuchi, Kennosuke Ohashi, Tsuyoshi Isaka, Noriko Sakamoto, Yosuke Kayama, Katsuyoshi Tojo, Michihiro Yoshimura, Kazunori Utsunomiya Cardiovascular Diabetology 2013, 12:71 (2 May 2013)

Abstract | Provisional PDF | PubMed | Cited on BioMed Central

3.

1023
Accesses

Review   Open Access Highly Accessed

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes

Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier, Anselm K Gitt, Martin Halle, Peter Bramlage, Petra-Maria Schumm-Draeger Cardiovascular Diabetology 2013, 12:62 (10 April 2013)

Abstract | Provisional PDF | PubMed

4.

999
Accesses

Original investigation   Open Access Highly Accessed

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

Odd Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle Cardiovascular Diabetology 2012, 11:3 (10 January 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

5.

990
Accesses

Original investigation   Open Access Highly Accessed

Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study

Tommy Jönsson, Yvonne Granfeldt, Bo Ahrén, Ulla-Carin Branell, Gunvor Pålsson, Anita Hansson, Margareta Söderström, Staffan Lindeberg Cardiovascular Diabetology 2009, 8:35 (16 July 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

6.

959
Accesses

Original investigation   Open Access Highly Accessed

Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes

Guoxin Tong, Ningfu Wang, Jianhang Leng, Xiaoshan Tong, Yun Shen, Jianmin Yang, Xianhua Ye, Liang Zhou, Yujie Zhou Cardiovascular Diabetology 2013, 12:67 (17 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

7.

954
Accesses

Original investigation   Open Access Highly Accessed

Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials

Maximilian von Eynatten, Yan Gong, Angela Emser, Hans-Juergen Woerle Cardiovascular Diabetology 2013, 12:60 (9 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

8.

901
Accesses

Original investigation   Open Access Highly Accessed

Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya Cardiovascular Diabetology 2012, 11:92 (6 August 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

9.

856
Accesses

Original investigation   Open Access

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study

Arne Ring, Tobias Brand, Sreeraj Macha, Kerstin Breithaupt-Groegler, Gudrun Simons, Beate Walter, Hans J Woerle, Uli C Broedl Cardiovascular Diabetology 2013, 12:70 (24 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

10.

844
Accesses

Original investigation   Open Access

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction

Jing Sun, Yunfei Pu, Peijian Wang, Sijiao Chen, Yu Zhao, Chan Liu, Qianhui Shang, Zhiming Zhu, Daoyan Liu Cardiovascular Diabetology 2013, 12:69 (22 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

11.

837
Accesses

Review   Open Access Highly Accessed

Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice

Jeanette Johansen, Alex K Harris, David J Rychly, Adviye Ergul Cardiovascular Diabetology 2005, 4:5 (29 April 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central | 1 comment

12.

795
Accesses

Review   Open Access Highly Accessed

How hyperglycemia promotes atherosclerosis: molecular mechanisms

Doron Aronson, Elliot J Rayfield Cardiovascular Diabetology 2002, 1:1 (8 April 2002)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

13.

764
Accesses

Original investigation   Open Access Highly Accessed

Effects of sitagliptin beyond glycemic control: focus on quality of life

Yoshiko Sakamoto, Jun-ichi Oyama, Hideo Ikeda, Shigetaka Kuroki, Shigeki Gondo, Taketo Iwamoto, Yasufumi Uchida, Kazuhisa Kodama, Atsushi Hiwatashi, Mitsuhiro Shimomura, Isao Taguchi, Teruo Inoue, Koichi Node, S-DOG [Saga Challenge Anti-Diabetes Observational Study for Sitagliptin (S-DOG)] investigators Cardiovascular Diabetology 2013, 12:35 (21 February 2013)

Abstract | Full text | PDF | ePUB | PubMed

14.

698
Accesses

Original investigation   Open Access Highly Accessed

Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS)

Eyal Leibovitz, Shmuel Gottlieb, Ilan Goldenberg, Natalie Gevrielov-Yusim, Shlomi Matetzky, Dov Gavish Cardiovascular Diabetology 2013, 12:53 (28 March 2013)

Abstract | Full text | PDF | ePUB | PubMed

15.

658
Accesses

Original investigation   Open Access

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report

Miao-yan Zheng, Ju-hong Yang, Chun-yan Shan, Hong-tao Zhou, Yan-guang Xu, Ying Wang, Hui-zhu Ren, Bao-cheng Chang, Li-ming Chen Cardiovascular Diabetology 2013, 12:73 (4 May 2013)

Abstract | Full text | PDF | ePUB | PubMed

16.

629
Accesses

Original investigation   Open Access Highly Accessed

Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study

Christine Berndt-Zipfel, Georg Michelson, Markus Dworak, Michael Mitry, Andrea Löffler, Andreas Pfützner, Thomas Forst Cardiovascular Diabetology 2013, 12:59 (8 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

17.

589
Accesses

Original investigation   Open Access Highly Accessed

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis

Samuel S Engel, Gregory T Golm, Deborah Shapiro, Michael J Davies, Keith D Kaufman, Barry J Goldstein Cardiovascular Diabetology 2013, 12:3 (3 January 2013)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

18.

585
Accesses

Review   Open Access Highly Accessed

What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?

Samir G Mallat Cardiovascular Diabetology 2012, 11:32 (10 April 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

19.

580
Accesses

Review   Open Access Highly Accessed

Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data

Michael E Cobble, Robert Frederich Cardiovascular Diabetology 2012, 11:6 (16 January 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

20.

569
Accesses

Original investigation   Open Access

The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats

Jianxin Lu, Jingzhang Ji, Howard Meng, David Wang, Bo Jiang, Lixin Liu, Edward Randell, Khosrow Adeli, Qing H Meng Cardiovascular Diabetology 2013, 12:58 (5 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

21.

538
Accesses

Review   Open Access Highly Accessed

Endothelial dysfunction: a comprehensive appraisal

Ricardo J Esper, Roberto A Nordaby, Jorge O Vilariño, Antonio Paragano, José L Cacharrón, Rogelio A Machado Cardiovascular Diabetology 2006, 5:4 (23 February 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

22.

535
Accesses

Original investigation   Open Access

Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study

Amanda J Cox, Fang-Chi Hsu, J Carr, Barry I Freedman, Donald W Bowden Cardiovascular Diabetology 2013, 12:68 (18 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

23.

472
Accesses

Original investigation   Open Access

Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects

Christian Cadeddu, Silvio Nocco, Davide Piano, Martino Deidda, Efisio Cossu, Marco Giorgio Baroni, Giuseppe Mercuro Cardiovascular Diabetology 2013, 12:66 (16 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

24.

467
Accesses

Original investigation   Open Access

Protein Kinase C inhibition ameliorates functional endothelial insulin resistance and Vascular Smooth Muscle Cell hypersensitivity to insulin in diabetic hypertensive rats

Xiao Lu, James S Bean, Ghassan S Kassab, Mark D Rekhter Cardiovascular Diabetology 2011, 10:48 (2 June 2011)

Abstract | Full text | PDF | PubMed

25.

462
Accesses

Original investigation   Open Access

The adaptability of red blood cells

Etheresia Pretorius Cardiovascular Diabetology 2013, 12:63 (11 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

Page 1 of 4

1 2 3 4  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.